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Problem identification: Colonoscopy is considered the most accurate
screening test for colorectal cancer. Despite favorable evidence,
publicity and funding, many patients refuse colonoscopy.

• This project aimed to investigate the reasons why patients
refuse colonoscopy, the screening rates for colonoscopy,
alternatives to colonoscopy and methods primary care
physicians can use to encourage patients to have colorectal
cancer screening.
Description of need: Colorectal cancer is second in both cancer
incidence and mortality in Vermont3. Despite its presence, screening for
colorectal cancer remains underused1. Nationally, only 59% of adults
over 50 have been screened for colorectal cancer2.
Efforts to increase rates of screening should focus on the primary care
setting, both provider and patient, where most referrals for colonoscopy
are made.

Public health cost:
• Colorectal cancer is the second-leading cancer in terms of both incidence
and mortality in Vermont.

Figure 1: CRC Incidence per 100,000

Figure 2: CRC Mortality per 100,000
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• Studies suggest that colorectal cancer screening is cost-effective. Less than
$30,000 must be spent per additional year of life gained. It has been
estimated that routine screening could save 18,800 lives per year.

Community perspective on colonoscopy:
Reasons cited for refusal:
“I don’t know what happened but [the colonoscopy] didn’t go well for someone I know.”
-BB (patient)
“I heard the prep is really unpleasant.”
-RM (patient)

“I don’t have insurance so I can’t afford a colonoscopy.”
-MP (patient)
“The idea of being sedated makes me really nervous. I think it’s just my hemorrhoids”
-AS (patient)
Expert perspective:
“Patients usually refuse colonoscopy because of fear of unknown, bad experiences of
previous friends or relatives. The key is the presentation.”
M.D. – name withheld

Project intervention and methodology:
1. Analyzed rates of colonoscopy screening in in Chester, the
Springfield Medical System, Windsor county, Vermont and the United
States.
2. Reviewed literature on colorectal cancer screening methods1.
3. Reviewed literature on best practices for getting patients screened in
the primary care setting4,5.
4. Created colorectal cancer screening review presentation for the staff
of Chester Family Medicine incorporating most recent
recommendations.
5. Presented for the group on my last day of the clerkship.

Region
Results/Data:

% of patients
ages 50-75
screened for
colorectal cancer

Chester Family
Medicine

56%*

Springfield
Medical System

54%*

Windsor
County 2

70%

Vermont 2

71%

U.S. 3

59%

*These internal Springfield Medical System data only include screening by colonoscopy.

What we can do to increase screening for colorectal cancer:
Using colloquial language, accessible numeracy, loss-framed and gain-framed
messages and completeness, providers are recommended6 to address:
• Probability of developing the cancer
• Operating characteristics of the screening test
• Likelihood screening will benefit the patient
• Potential burdens of the test

Effectiveness of response and limitations:
• My presentation was attended by the 15-person staff of Chester
Family Medicine and a Springfield Medical Systems executive.
• A discussion followed that built upon the information I presented and
suggested that the staff was interested in screening more patients in
the future.
• Multiple staff members commented that they plan to change their
practices based on the information presented.

• The Springfield Medical Systems executive who attended explained
for the group that for patients without insurance, there is an
assistance program available that will pay for colonoscopy and other
procedures completely.
• There was insufficient time to follow up on how many patients were
screened after my presentation.

Recommendations for the future:
• Studies have shown that Personal Risk Communication can increase
patient uptake of screening tests6. Therefore, rapid, point-of-care
calculation of a patient’s lifetime risk for colorectal cancer would be
an invaluable tool for primary care physicians.

• Currently there is no smart phone app available to calculate a
patient’s risk of colorectal cancer. Implementation of a smart phone
app with this capability app would take advantage of Personal Risk
Communication and give primary care physicians a new and muchneeded tool.
• A rendering that incorporates some well-proven risk factors for
colorectal cancer is shown in the image at right.

Figure Colorectal cancer risk
assessment app prototype
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